Prostate cancer : a comprehensive perspective /
Saved in:
| Imprint: | London : Springer, 2013. |
|---|---|
| Description: | 1 online resource (xxxi, 1141 p.) : ill. (some col.) |
| Language: | English |
| Subject: | |
| Format: | E-Resource Book |
| URL for this record: | http://pi.lib.uchicago.edu/1001/cat/bib/9850519 |
Table of Contents:
- Part I: Basic Scientific Foundation
- Development, Applied and Surgical Anatomy of the Prostate
- Molecular Biology and Prostate Cancer
- Endocrine Mechanisms, Androgen Receptor and Carcinogenesis, and Hormone Escape
- Molecular Mechanisms of Castrate Resistant Prostate Cancer
- Immunologic Aspects of Prostate Cancer
- Stem Cells in Carcinogenesis of the Prostate
- Murine Models of Prostate Cancer
- Prostate Cancer and the Metabolic Syndrome
- Inflammation and Cancer of the Prostate
- HIV and Prostate Cancer
- Prostate Cancer Genetics
- Gene Expression Pro fi ling and Somatic Genome Changes
- The Proteomic Approach to Prostate Cancer
- Epigenetic Changes in Prostate Cancer
- Biomarkers of Potential Therapeutic Value
- Prostate Tissue Banking
- Molecular Imaging in Diagnostics
- Molecular Risk Profiling
- Premalignant Lesions of the Prostate
- The Pathology of Prostatic Carcinoma
- The Pathology of Non-epithelial Tumors of the Prostate
- Neuroendocrine Prostate Cancer
- Part II: Epidemiology, Screening, and Chemoprevention
- Epidemiology of Prostate Cancer
- Racial Disparities and the Global Picture
- Natural History of Prostate Cancer
- Population-based Health Systems as a Foundation for Prostate Cancer Control Research: The Cancer Research Network
- Screening for Prostate Cancer
- Next Generation Screening Tests
- Diet and Prostate Cancer: A Holistic Approach to Management
- Estrogens in Prostate Cancer
- Vitamin D and Prostate Cancer
- The Role of 5[a]-Reductase Inhibitors (5-ARIs)
- Other Pharmaceutical Agents in the Chemoprevention of Prostate Cancer
- Part III: Diagnosis and Staging
- Early Detection and Patient Risk Stratification in Prostate Cancer
- Tumor Markers
- Prostate Specific Membrane Antigen-Based Diagnostics
- Prostate Specific Membrane Antigen-Based Therapeutics
- Presentation and Symptomatology of Prostate Cancer
- The Role of Ultrasonography
- The Use of Magnetic Resonance Imaging in the Management of Prostate Cancer
- The Role of Functional Magnetic Resonance Imaging Techniques
- Prostate Biopsy
- The Staging of Prostate Cancer
- Nuclear Medicine in Prostate Cancer
- Nanotechnology and Prostate Cancer
- Part IV: Risk Assessment and Decision-Making Strategies for Localized Prostate Cancer
- Disease Risk Stratification
- Nomograms in Prostate Cancer
- Comparative Effectiveness of Treatment Alternatives for Localized Prostate Cancer
- Part V: Management of Localized Disease
- Radical Treatment for Localized Disease: An Overview of Options and Strategies for Decision Making
- Quality of Life and Management of Localized Disease
- Active Surveillance for Favorable-Risk Prostate Cancer
- Anesthesia for Robotic-Assisted Prostatectomy
- Retropubic Radical Prostatectomy: The Technique
- Retropubic Radical Prostatectomy: The Results
- Radical Perineal Prostatectomy
- Laparoscopic Radical Prostatectomy: The Technique
- Laparoscopic Radical Prostatectomy: The Results
- Robotic-Assisted Radical Prostatectomy: The Technique
- Lymph Node Dissection in Prostate Cancer Surgery
- External Beam Radiotherapy for Low-Risk Prostate Cancer
- Prostate Brachytherapy: Low Dose Rate
- Prostate Brachytherapy: High Dose Rate
- Intensity-Modulated Radiotherapy
- Proton Beam Therapy and Novel Radiotherapeutic Approaches to the Treatment of Prostate Cancer
- Prostate Cryotherapy
- Focal Therapies for Localized Prostate Cancer
- Part VI: Failure and Management of Recurrent, Locally Advanced, and Advanced Disease
- Biochemical Failure in Prostate Cancer
- The Phenomenon of PSA Bounce After Radiation Therapy
- Management of Locally Recurrent Disease
- Management of High-Risk/Locally Advanced Disease
- Radiotherapy Plus Hormonal Therapy
- Watchful Waiting in Advanced Prostate Cancer
- Androgen and Androgen Receptor-Directed Therapy as Initial Treatment for Prostate Cancer
- Hormone-Based Therapies for Castration-Resistant Prostate Cancer
- Toxicity of Androgen Deprivation Therapy in Hormone-Sensitive Prostate Cancer
- Chemotherapy and Novel Systemic Approaches in the Treatment of Metastatic Castration Resistant Prostate Cancer
- Immunotherapy
- Bone Health: Prevention of Skeletal-Related Events and Palliative Care
- Part VII: Outcomes and Complications After Treatment
- Assessment of Treatment Outcomes Following Prostate Cancer Therapy
- Urinary Incontinence
- Erectile Dysfunction
- Immediate/Early Surgical Complications
- Population-Based Outcomes Following Treatment of Clinically-Localized Prostate Cancer
- Management of Radiation Adverse Effects
- Management of Complications Following Minimally Invasive Prostate Cancer Therapy
- Part VIII: Management of Emergencies and Palliative Care
- Prostate Cancer Emergencies
- Management of Bone Metastases
- Pain Relief in Metastatic Cancer
- The Psychosocial Impact of Prostate Cancer
- Nursing Issues in Prostate Cancer.